DNMT3B- SLC25A6 axis-mediated DNA methylation regulates ferroptosis to promote paclitaxel resistance in triple-negative breast cancer
Frontiers in Cell and Developmental Biology · 30.07.2026 · 14
DOI: 10.3389/fcell.2026.1887314 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 30.07.2026. Verfasst von Hao Wu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Triple negative breast cancer (TNBC) is the most malignant type of breast cancer, and its treatment usually uses paclitaxel for chemotherapy. However, TNBC cells are increasingly resistant to paclitaxel. In the context of paclitaxel resistance, we investigated the role of DNA methylation and the DNA methyltransferase DNMT3B methylation regulatory proteins, as well as their interaction with ferroptosis regulator SLC25A6, in regulating paclitaxel resistance and ferroptosis in TNBC.
Methods
We used database integration analysis methods, combined with bioinformatics screening, in vitro and in vivo cell and animal experimental models to analyze DNA methylation and the effect of DNMT3B on SLC25A6 DNA methylation. We explored the effects of the DNMT3B-SLC25A6 regulatory axis on ferroptosis and paclitaxel resistance using electron microscopy, fluorescent probes, and detection of key biomarkers. Statistical significance was evaluated using Student’s t-test and analysis of variance (ANOVA).
Results
DNMT3B was significantly overexpressed in paclitaxel-resistant TNBC tissues and cell lines, correlating with enhanced proliferation, migration, and ferroptosis. Mechanistically, DNMT3B induced DNA methylation of SLC25A6 through its 252-bp CpG island, inhibited its protein expression, and triggered ferroptosis by disrupting mitochondrial function and redox balance, leading to paclitaxel resistance in TNBC.
Conclusion
In paclitaxel-resistant TNBC, DNMT3B regulates SLC25A6 expression via DNA methylation, and the DNMT3B-SLC25A6 regulatory axis acts as a central regulator of ferroptosis, promoting paclitaxel resistance in TNBC by suppressing ferroptosis via oxidative stress imbalance. These findings provide promising therapeutic targets for the intervention of TNBC paclitaxel resistance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China.
- Breast Center, West China Hospital, Sichuan University, Chengdu, China.
Zitieren
APA
Wu, H., Zhu, T., Li, T., & Du, Z. (2026). DNMT3B- SLC25A6 axis-mediated DNA methylation regulates ferroptosis to promote paclitaxel resistance in triple-negative breast cancer. Frontiers in Cell and Developmental Biology, 14. https://doi.org/10.3389/fcell.2026.1887314
Vancouver
Wu H, Zhu T, Li T, Du Z. DNMT3B- SLC25A6 axis-mediated DNA methylation regulates ferroptosis to promote paclitaxel resistance in triple-negative breast cancer. Frontiers in Cell and Developmental Biology. 2026;14. doi:10.3389/fcell.2026.1887314
BibTeX
@article{Wu2026,
author = {Wu, Hao and Zhu, Tao and Li, Tianyuan and Du, Zhenggui},
title = {DNMT3B- SLC25A6 axis-mediated DNA methylation regulates ferroptosis to promote paclitaxel resistance in triple-negative breast cancer},
journal = {Frontiers in Cell and Developmental Biology},
year = {2026},
volume = {14},
doi = {10.3389/fcell.2026.1887314}
}
EUVIMED